CORC

在结果中检索

CORC

浏览/检索结果: 共141条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Observations of atmospheric CO2 and CO based on in-situ and ground-based remote sensing measurements at Hefei site, China 期刊论文
SCIENCE OF THE TOTAL ENVIRONMENT, 2022, 卷号: 851
作者:  Shan, Changgong;  Wang, Wei;  Xie, Yu;  Wu, Peng;  Xu, Jiaqing
收藏  |  浏览/下载：38/0  |  提交时间：2022/12/22
掺杂元素Ti对WS2薄膜结构和摩擦学性能的影响 期刊论文
表面技术, 2022, 卷号: 51, 期号: 06, 页码: 239-247+266
作者:  张赵云;  段泽文;  江海霞;  张贝贝;  赵晓宇
收藏  |  浏览/下载：15/0  |  提交时间：2022/07/19
Integrated ELM and divertor power flux control using RMPs with low input torque in EAST in support of the ITER research plan 期刊论文
NUCLEAR FUSION, 2021, 卷号: 61
作者:  Jia, Manni;  Loarte, Alberto;  Sun, Youwen;  Ma, Qun;  Wu, Xuemin
收藏  |  浏览/下载：66/0  |  提交时间：2021/11/01
Observation of enhanced pedestal turbulence during ELM mitigation with resonant magnetic perturbation on EAST 期刊论文
AIP ADVANCES, 2021, 卷号: 11
作者:  Zhong, Fubin;  Zhang, Tao;  Wang, Yumin;  Wen, Fei;  Huang, Jia
收藏  |  浏览/下载：25/0  |  提交时间：2021/11/01
低噪声相干光学及射频频率标准同时解调装置 专利
专利号: CN109768832A, 申请日期: 2019-05-17, 公开日期: 2019-05-17
作者:  冯子桐;  杨飞;  蔡海文;  张茜;  吴瑞
收藏  |  浏览/下载：37/0  |  提交时间：2019/12/30
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:  Gong, Guozhong;  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun
收藏  |  浏览/下载：61/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：50/0  |  提交时间：2019/12/05
Recent advances in EAST physics experiments in support of steady-state operation for ITER and CFETR 期刊论文
NUCLEAR FUSION, 2019, 卷号: 59
作者:  Wan, B. N.;  Liang, Y.;  Gong, X. Z.;  Xiang, N.;  Xu, G. S.
收藏  |  浏览/下载：151/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace